Viewing Study NCT06637150


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2025-12-31 @ 7:52 AM
Study NCT ID: NCT06637150
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-15
First Post: 2024-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module